News | May 27, 2021
Sun Pharma Q4 FY21 net profit up 124%
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19
This oxygen is being provided free-of-cost to several state governments across the country to bring immediate relief to over 1 lakh patients on a daily basis
_256_384.jpeg)
Against the present demand from 20 states of 6,785 MT/day of Liquid Medical Oxygen, the Government of India has from 21st April allocated 6,822 MT/day to these states
Acquisition of A&C expands Aceto’s Western manufacturing footprint
The consideration to be paid will be AUD 2.0 mn for 12.5% stake.
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
The company has reported total income of Rs.25699.68 crores during the 9 months period ended December 31, 2020.
Subscribe To Our Newsletter & Stay Updated
